High Sensitive and Accurate Analysis of Nitrosamines Using GC/MS/MS
Applications | 2021 | ShimadzuInstrumentation
GC/MSD, GC/MS/MS, GC/QQQ
IndustriesPharma & Biopharma
ManufacturerShimadzu
Key wordsapi, apiⅰ, apiⅱ, apiⅲ, apiⅳ, apiⅴ, neipa, ndipa, ndba, ndea, ndma, nitrosamines, std, substance, news, area, iii, kinds, carcinogenic, drug, reproducibility, application, nitrosoethylisopropylamine, nitrosodiisopropylamine, nitrosodibutylamine, entitled, measuring, impurities, controlled, five, dynamic, high, triple, mutagenic, nitrosodiethylamine, values, analytical, limit, wide, instruments, prepared, excellent, allowable, quadrupole, conditions, nitrosodimethylamine, samples, accuracy, spectrometer, despite
Similar PDF
High Sensitive and Accurate Analysis of Nitrosamines Using GC/MS/MS
2021|Shimadzu|Applications
GC-MS GCMS-TQ™8050 NX Application News High Sensitive and Accurate Analysis of Nitrosamines Using GC/MS/MS R. Kitano User Benefits Analyze trace quantities of nitrosamines with state-of-the-art detector. MRM measurements eliminate matrix interferences to ensure reliable target compound detection. …
Key words
api, apiapiⅰ, apiⅰapiⅱ, apiⅱapiⅲ, apiⅲapiⅳ, apiⅳapiⅴ, apiⅴneipa, neipandipa, ndipandba, ndbandea, ndeandma, ndmanitrosamines, nitrosaminesstd, stdsubstance, substancenews
Quantitation of 7 Nitrosaminesin API by HSGC-MS/MS as per proposed USP General Chapter <1469>
2021|Shimadzu|Applications
Gas Chromatograph Mass Spectrometer GCMS-TQTM8050 NX, HS-20 Application News Quantitation of 7 Nitrosamines in API by HSGC-MS/MS as per proposed USP General Chapter <1469> Nitish Suryawanshi, Dheeraj Handique, Prashant Hase, Sanket Chiplunkar, Durvesh Sawant, Aseem Wagle, Rahul Dwivedi, Jitendra Kelkar…
Key words
nmprz, nmprzloq, loqneipa, neipandipa, ndipandpa, ndpandea, ndeanitrosamine, nitrosaminendma, ndmandba, ndbabelow, belowppb, ppbratio, rationitroso, nitrosomin, minarea
Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances -
2020|Shimadzu|Guides
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Key words
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsdrug, drugmutagenicity, mutagenicityolmesartan, olmesartanndba, ndbapharmaceuticals
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Technical notes
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Key words
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapmass, massaquisition, aquisitionexactive, exactivesource, sourceloop, loopkpa